Personalis

The firm shared performance study results at a recent meeting and said it has begun processing samples for its first major pharma customer. 

The company will provide comprehensive genomic tumor testing and will work with UCSD researchers to develop new biomarkers and test its new liquid biopsy assay.

Investigators intend to offer Personalis' comprehensive genomics testing to consenting patients for both clinical use and to aggregate data for ongoing research.